Skip to main content

Table 5 Current and prior neuropathic pain treatments

From: Are treatment benefits in neuropathic pain reflected in the self assessment of treatment questionnaire?

# of participants # of treatments Anticonvulsant or anti-seizure medications Antidepressant medications Opioid medications Non-Opioid Analgesic medications Topical treatments Qutenza patch
Total 95 32 15 11 14 8 10
N=44   (73%) (34%) (25%) (32%) (18%) (23%)
PHN 23 5 3 4 1 5 2
N=8   (63%) (38%) (50%) (13%) (63%) (25%)
PDPN 42 16 9 5 7 2 1 1
N=20   (80%) (45%) (25%) (35%) (10%) (5%)
HIV-AN 30 11 3 3 6 1 7
N=16   (69%) (19%) (19%) (38%) (6%) (44%)
  1. 1One PDPN participant was previous treated with Qutenza but did not recall the treatment. Therefore, this participant was not asked about the treatment experience.